Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:38 AM
Ignite Modification Date:
2025-12-25 @ 3:38 AM
NCT ID:
NCT06934902
Eligibility Criteria:
Inclusion Criteria:
* Be 18 years old to 40 years old
* Be right-handed
* Do not wear glasses
* Have a mobile-phone compatible with the application, minimum 6rd generation Android operating system, with geo-localization activated and accepted by the user
* Undertake to comply with the instructions and recommendations for MRI examination
* Provide informed written consent to participate in the study
Exclusion Criteria:
* History of known neurological or psychiatric illness
* Cognitive problems limiting the understanding of instructions
* Recent taking psychotropic drugs (antidepressants, anxiolytics, antipsychotics). The main treatments not authorized during this research are the following: Psychotropic treatments (drugs that can induce changes in perception, sensation, mood, consciousness or behavior). Like what:
* Antipsychotics (valproic acid, amisulpride, aripiprazole, clozapine, cyamemazin, haloperidol, loxapine, olanzapine, risperidone).
* Antidepressants (Amitriptyline, Citalopram, Clomipramine, Duloxetine, Escitalopam, Fluoxetine, Mianserine, Mirtazapine, Nortriptyline, Paroxetine, Sertraline, Venlafaxine).
* Anxyolitics
* Pregnant or breastfeeding women
* Persons deprived of their liberty by a judicial or administrative decision
* Persons admitted to a health or social institution for purposes other than research
* Adults subject to a legal protection measure (guardianship, curatorship)
* Persons not affiliated to a social security scheme or beneficiaries of a similar scheme
* Participation in another research study of the current study
* Contraindication for fMRI scanning
* Participant not agreeing to be informed in the event of the incidental discovery of an anomaly on MRI
• For visit number 2 :
* Alcohol consumption (\> 3 drinks) in the 24h before the experiment
* Alcohol consumption the day of the experiment
* Cafeine consumption 1 hour or less before the experiment
* Drug consumption within the 24h preceding the experiment
* Antimalarial treatment within the 3 days preceding the experiment
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
40 Years
Study:
NCT06934902
Study Brief:
Protocol Section:
NCT06934902